• Ligand Pharmaceuticals CLO and Secretary Andrew Reardon exercised employee stock options for 5,000 shares at $52.27 on June 1, 2026.
• Reardon sold 5,000 shares on June 1 in multiple trades priced about $223.95 to $230.41.
• He reported 41,382 shares owned following the transactions.
• Reardon reported 39,444 employee stock options remaining after the exercise.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ligand Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0002001011-26-000083), on June 02, 2026, and is solely responsible for the information contained therein.